Treatment of acquired reactive perforating collagenosis with dupilumab in a patient with end-stage renal disease

Dermatol Ther. 2022 Dec;35(12):e15926. doi: 10.1111/dth.15926. Epub 2022 Oct 17.

Authors

Yu Jin Lee¹, June Hyunkyung Lee¹, Jae Eun Choi¹, Tae Young Han¹

Affiliation

¹ Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea.

PMID: 36219541
DOI: 10.1111/dth.15926

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Kidney Failure, Chronic* / complications
Skin Diseases*
Soft Tissue Injuries*

Substances

dupilumab
Antibodies, Monoclonal, Humanized